查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1179904

聽診器全球市場 2023-2030

Global Stethoscope Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

在預測期內（2023-2030 年），聽診器的全球市場規模預計將以 5.6% 的複合年增長率增長。

聽診器可以放大身體內部的聲音，例如心音、肺音和碗音。 所有內臟聲音都有一個“標準”頻段，醫生在檢查患者時會聽到這些頻段。

市場動態

不斷增長的老年人口和相關的慢性病推動了全球聽診器市場的增長。

全球老年人口和與年齡相關的慢性病不斷增加將推動市場增長。

根據國家老齡化委員會的數據，65 歲以上的成年人中約有 80% 至少患有一種疾病，68% 患有兩種或兩種以上疾病。 老年人的常見疾病包括慢性阻塞性肺疾病（COPD）、心力衰竭、慢性腎髒病（CKD）、缺血性心髒病（或冠狀動脈疾病）和高血壓（高血壓）。 在預測期內，不斷增長的老年人口和相關的慢性病推動了全球聽診器市場的增長。 例如 例如，根據美國經濟和社會事務局的數據，2020年65歲及以上的人口將達到約7.27億，預計到2050年將達到15億。 到 2050 年，全球 65 歲及以上人口的比例預計將達到 16%。 根據美國國立衛生研究院的數據，到 2030 年，85 歲及以上的人口將激增。

此外，根據美國肺臟協會的數據，2020 年將有 1250 萬人（佔成年人的 5.0%）被診斷患有 COPD（慢性阻塞性肺病、慢性支氣管炎、肺氣腫）。 與較年輕的年齡組相比，65 歲及以上人群的比例更高。 根據美國心臟協會 2022 年心髒病和中風統計更新情況說明書，CVD 將在 2020 年導致全球約 1905 萬人死亡。 因此，上述數據表明，在預測期內，老年人口和相關慢性病的增加將推動全球聽診器市場的增長。

高成本和缺乏熟練醫務人員阻礙了全球聽診器市場的增長。

然而，一些變體的高成本和熟練的醫療保健專業人員的短缺將成為市場的製約因素。 一些最先進的變體對於一些醫療保健專業人員來說太貴了，無法負擔。 同樣，缺乏專業的醫療保健提供者和對高端產品的了解不足可能會阻礙該行業的發展。

COVID-19 影響分析

COVID-19 的流行增加了對醫療保健援助的需求，並且由於 COVID-19 是一種呼吸系統疾病，因此在治療環境中擴大對肺部和心臟的關注至關重要。 在這種特殊情況下，現有的治療方法會出現各種困難的結果，因此這裡也正在尋求基於技術的醫療保健解決方案。 在世界科技繁榮時期，無線聽診器對於治療這種罕見疾病至關重要，並且可以將感染風險降到最低。 因此，對醫療保健援助的日益增長的需求和由流行病驅動的聽診器創新正在對全球市場產生積極影響。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 老年人口增加
      • 創新與發展
    • 約束因素
      • 醫療保健專業人員成本高且短缺
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 電子產品
  • 聲學

第 8 章的設計

  • 單頭
  • 雙頭
  • 三重頭

第 9 章最終用戶

  • 醫院和診所
  • 醫療機構
  • 門診手術中心 (ASC)
  • 家庭醫療機構
  • 其他

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 競爭場景
  • 產品基準
  • 主要發展和戰略

第12章公司簡介

  • 3M
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Welch Allyn
  • American Diagnostic Corporation
  • EKuore
  • Dongjin Medical Co. Ltd
  • Cardionics
  • Eko Devices
  • Medline Industries Inc.
  • Smiths Medical
  • GF Health Products Inc.

第13章 DataM

簡介目錄
Product Code: DMMD1261

Market Overview

The global stethoscope market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 5.6% during the forecast period (2023-2030).

The stethoscope allows the amplification of internal body sounds from the heart, lungs, and bowls. Every internal organ sound has a "standard" frequency range that doctors listen to during patient checkups.

Market Dynamics

The rising geriatric population and related chronic diseases promote the global stethoscope market growth.

The growing geriatric population and age-related chronic diseases worldwide will fuel the market growth.

According to the National Council on Aging, Inc., around 80% of adults 65 and older have at least one condition, while 68% have two or more. A few of the most common conditions among older adults are Chronic obstructive pulmonary disease (COPD), Heart failure, chronic kidney disease (CKD), Ischemic heart disease (or coronary heart disease), Hypertension (high blood pressure), and others. The growing geriatric population and related chronic cases fuel the global stethoscope market growth during the forecast period. For instance, according to the United States Department of Economics and Social Affairs, about 727 million people aged 65 and over in 2020 are estimated to reach 1.5 billion by 2050. share of the population 65 and above globally is expected to be 16% by 2050. According to NIH, by 2030, the population of people aged 85 and over will rise rapidly.

Moreover, according to the American Lung Association, in 2020, 12.5 million people, or 5.0% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease, chronic bronchitis, or emphysema. Rates were higher among those 65 and older compared to younger age groups. According to the 2022 heart disease and Stroke Statistics Update Fact Sheet from American Heart Association, Inc., CVD accounted for approximately 19.05 million global deaths in 2020. Thus, the above data indicate that the growing geriatric population and related chronic diseases will drive the growth of the worldwide stethoscope market during the forecasted period.

The high cost and dearth of skilled healthcare professionals will hamper the global Stethoscope market growth.

However, the high cost of some variants and the dearth of skilled healthcare professionals will be a market-restraining aspect. Some of the cutting-edge technology variants are costly, and a few healthcare professionals cannot afford them. Likewise, the shortage of professional healthcare providers and inadequate understanding of high-end products will hinder the industry's growth.

COVID-19 Impact Analysis

Because of the COVID-19 pandemic, the need for healthcare assistance is raised and since COVID-19 is a respiratory disease, expanding attention to the lungs and heart in therapeutic circumstances is vital. Again, tech-enabled healthcare answers are being pursued when this unique situation leads to different outcomes that are challenging to treat with existent practices. Wireless stethoscopes are essential to the worldwide technology boom for treating this unusual disease with minimal risk of transmission. Therefore, the increased need for healthcare assistance and pandemic-driven innovations in stethoscopes has positively impacted the global market.

Segment Analysis

The electronic stethoscope is predicted to grow at the fastest CAGR during the forecast period (2022-2029)

An electronic stethoscope electronically amplifies body sounds. Since the sound signals are transmitted electronically, they can be wireless, provide noise reduction and interfaced with computers, thereby can be further investigated and stored for future usefulness. Electronic stethoscopes are anticipated to boost at a high CAGR during the projection years owing to the new product developments and introductions into the market. According to For instance, in August 2021, Eko Devices, Inc. launched its DUO ECG + Digital Stethoscope. This two-in-one electronic stethoscope tracks electrical activity and can be integrated with hospital electronic health records. Similarly, in 2020, Thinklabs One introduced Safe Distance AuscultationTM, a technologically sophisticated digital stethoscope that allows healthcare experts to be safe during COVID-19. Likewise, in April 2020, Polish telemedicine innovations company StethoMe launched its artificial intelligence wireless stethoscope after its current collaborations with MaQuestionMedicale and HomeDoctor, prominent European telemedicine providers.

Similarly, in April 2022, the Centre for Development of Advanced Computing (C-DAC) based in Mohali designed a wireless electronic stethoscope that allows doctors from remote locations to diagnose patients' heartbeats. Again, in April 2022, Israeli startup Sanolla Ltd. received the United States Food and Drug Administration 510(k) clearance for its smart-infrasound stethoscope Vox. Thus, the abovementioned data indicates that the increasing product developments and introductions contribute to the growth of the electronic stethoscope segment in the forecasted period.

Geographical Analysis

The North American region dominates the global Stethoscope market.

The initiatives by various government and non-government organizations to raise awareness & understanding of cardiac and pulmonary diseases are fueling the North American stethoscope market growth at a high CAGR. For example, a national initiative called "Million Hearts 2022" is being followed to avert 1 million heart attacks within five years. It is a joint endeavor of the Centers for Disease Control and Prevention and the Centers for Medicare & Medicaid Services. Likewise, the National Heart, Lung, and Blood Institute has started a national campaign: Learn More, Breathe Better, to expand awareness & understanding of COPD and its risk factors. Additionally, this campaign supports earlier detection and treatment in slowing the disease and enhancing the quality of life.

Furthermore, different market developments in this region also contribute to the North American stethoscope market growth. For instance, in November 2021, eMurmur, a global healthcare technology partner, released the world's first open software platform for advanced digital auscultation (stethoscope technology), presently available in the United States. Similarly, in April 2022, Sanolla introduced the AI-ready VoqX infrasound stethoscope for clinical use in the United States. Again, in June 2021, HD Medical made its flagship product, HD Steth, available online through Stethoscope.com, one of the leading online stethoscope and medical product distributors in the United States.

Additionally, the growing number of hospital visits in North America ensures the hold of North America over the global stethoscope market. According to the CDC, about 83.4% of adults visited a healthcare professional in the U.S. in 2020. The number of visits in the U.S. was 860.4 million, and the percentage of visits made to primary care physicians was 51.2%. Therefore, the above data indicate that North America will dominate the global stethoscope market throughout the forecast period.

Competitive Landscape

The Stethoscope market is moderately competitive due to the presence of key local and global players. Some key players are Welch Allyn, 3M, American Diagnostic Corporation, EKuore, Dongjin Medical Co. Ltd, Cardionics, Eko Devices, Medline Industries Inc., Smiths Medical and GF Health Products Inc. The key players keep the majority of their market share to themselves through innovations, product launches, collaborations, acquisitions, and alliances. For instance, in October 2020, 3M and Eko formed a partnership to combine 3M's Littmann stethoscope with Eko's digital innovations.

3M

Overview:

3M is a leading manufacturer all over the world. It has a global presence and is headquartered in Saint Paul, Minnesota, the United States, which was founded on June 13, 1902. 3M deals with 60,000 various products under many brands; the product categories are adhesives, abrasives, laminates, passive fire protection, personal protective equipment, window films, paint protection films, dental and orthodontic products, electrical and electronic connecting and insulating materials, medical products, car-care products, electronic circuits, healthcare software and optical films.

Product Portfolio:

The 3M product portfolio of Stethoscope has 3M Littmann CORE Digital Stethoscope: The 3M Littmann CORE Digital Stethoscope delivers up to 40x amplification (at peak frequency versus analog mode), active noise cancellation, in-app sound wave visualization and other powerful features developed to give a clearer picture of patient health.

The global stethoscope market report would provide access to approximately 40 + market data tables, 45 + figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The Increasing Geriatric Population
      • 4.1.1.2. Innovations And Developments
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost and Lack of Healthcare Professionals
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Electronic
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Acoustic

8. By Design

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 8.1.2. Market Attractiveness Index, By Design
  • 8.2. Single Head
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Double Head
  • 8.4. Triple Head

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals And Clinics
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Healthcare Institutions
  • 9.4. Ambulatory surgical centers (ASCs)
  • 9.5. Home care Settings
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Design
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Product Benchmarking
  • 11.3. Key Developments and Strategies

12. Company Profiles

  • 12.1. 3M
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Welch Allyn
  • 12.3. American Diagnostic Corporation
  • 12.4. EKuore
  • 12.5. Dongjin Medical Co. Ltd
  • 12.6. Cardionics
  • 12.7. Eko Devices
  • 12.8. Medline Industries Inc.
  • 12.9. Smiths Medical
  • 12.10. GF Health Products Inc.

LIST NOT EXHAUSTIVE

13. DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us